Browsing Tag
N-22 Glenosphere
1 post
FDA clears Shoulder Innovations’ second implant line for metal-sensitive patients
Shoulder Innovations has launched its FDA-cleared N-22 Humeral Head for metal-sensitive patients as quarterly revenue rises 56%, expanding a specialty implant strategy inside a still loss-making medtech business.